BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34355644)

  • 1. Treatment of childhood acute lymphoblastic leukemia in Iraq: a 17-year experience from a single center.
    Al-Hadad SA; Al-Jadiry MF; Ghali HH; Al-Badri SAF; Al-Saeed RM; Al-Darraji AF; Sabhan AH; Fadhil SA; Hussein HM; Abed WM; Ameen NA; Sahan JKA; Jaafar GQ; Abed AR; Mohamed S; Moleti ML; Piciocchi A; Foà R; Testi AM
    Leuk Lymphoma; 2021 Dec; 62(14):3430-3439. PubMed ID: 34355644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.
    Jaime-Pérez JC; López-Razo ON; García-Arellano G; Pinzón-Uresti MA; Jiménez-Castillo RA; González-Llano O; Gómez-Almaguer D
    Arch Med Res; 2016 Nov; 47(8):668-676. PubMed ID: 28476194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
    Antillón FG; Blanco JG; Valverde PD; Castellanos M; Garrido CP; Girón V; Letona TR; Osorio EJ; Borrayo DA; Mack RA; Melgar MA; Lorenzana R; Ribeiro RC; Metzger M; Conter V; Rossi E; Valsecchi MG
    Cancer; 2017 Feb; 123(3):436-448. PubMed ID: 27683100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center.
    Kocak U; Gursel T; Kaya Z; Aral YZ; Albayrak M; Keskin EY; Belen B; Isık M; Oner N
    Pediatr Hematol Oncol; 2012 Mar; 29(2):130-40. PubMed ID: 22376016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
    Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
    Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India.
    Trehan A; Bansal D; Varma N; Vora A
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27762058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Retrospective Cohort Study.
    Dujua AC; Hernandez FG
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):e116-e123. PubMed ID: 28085747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
    Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical presentation, hematologic features and treatment outcome of childhood acute lymphoblastic leukemia: a review of 73 cases in Hong Kong.
    Ma SK; Chan GC; Ha SY; Chiu DC; Lau YL; Chan LC
    Hematol Oncol; 1997 Aug; 15(3):141-9. PubMed ID: 9600113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
    Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
    Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
    Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
    Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.
    Jaime-Pérez JC; Jiménez-Castillo RA; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Marfil-Rivera LJ; Gómez-Almaguer D
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of children with acute lymphoblastic leukemia in Cambodia.
    Küpfer L; Meng B; Laurent D; Zimmermann M; Niggli F; Bourquin JP; Malene I
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29184. PubMed ID: 34319655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes in childhood acute lymphoblastic leukemia: 40-year experience from a single tertiary center in Thailand.
    Chavananon S; Sripornsawan P; Songthawee N; McNeil EB; Chotsampancharoen T
    Pediatr Hematol Oncol; 2023; 40(8):739-751. PubMed ID: 36940098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
    Hassan IB; Kristensen J; Alizadeh H; Bernsen R
    Med Oncol; 2013 Jun; 30(2):519. PubMed ID: 23468219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.